1. Volume 145, Issue 4, Pages 758-765.e2 (October 2013)
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial 
Jacques Cosnes, Anne Bourrier, David Laharie, Stéphane Nahon, Yoram Bouhnik, Franck Carbonnel, Matthieu Allez, Jean–Louis Dupas, Jean–Marie Reimund, Guillaume Savoye, Pauline Jouet, Jacques Moreau, Jean–Yves Mary, Jean–Frédéric Colombel 
Gastroenterology 
Volume 145, Issue 4, Pages e2 (October 2013)
DOI: /j.gastro
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
Proportion of patients who were treated with immunosuppressant therapy (including immunomodulators and anti-TNF) per trimester over time. All trimesters of follow-up are included.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
Proportion of patients in corticosteroid-free, anti-TNF–free remission per trimester over time. The concomitant proportions were significantly different only at trimester 3 (P < .05). Trimesters ended by a missing visit are excluded.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

4. Figure 3
Kaplan–Meier estimates of the time without CD-related perianal surgery.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

5. Supplementary Figure 1 Trial profile.
Gastroenterology  , e2DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions